Category: European Union
-
Litigation funders are âcentralâ to class action regime, says UK Competition Appeal Tribunal chairman Hodge Malek KC
âWe donât want to kill off the industry [and] we want the best for everyone, including the funders,â Mr. Malek said at the 2nd Annual LF Dealmakers Europe in London yesterday.
-
AI patent-eligibility: spotting hallucinations over value-adds
While AI is accelerating discovery, designing software, and shaping new chemical compounds, some industry voices question whether we have become too dependent on it to invent, and how the pitfalls of that over-dependence are being materialized.
-
Novo Nordisk lets key Ozempic patent lapse in Canada, despite being worldâs second-largest semaglutide market
Novo Nordisk has continued to pay for a key Ozempic patent in several jurisdictions across the world, and even obtained an adjusted expiration date in the U.S., but the company stopped paying fees in Canada as far back as 2018, records show.
-
Standardization âindispensableâ in making Europe the âquantum continentâ: ETSI responds to proposed EU quantum strategy
ETSI is among 168 respondents to the EUâs call for evidence on its incoming Quantum Strategy, which is aiming to make Europe take the lead in the global quantum race, with some stating that enhancing IP commercialisation mechanisms will also be key.